期刊文献+

氟伐他汀对肺动脉高压大鼠5-羟色胺转载体表达的影响 被引量:2

Effect of fluvastatin on serotonin transporter expression in rats with pulmonary arterial hypertension
下载PDF
导出
摘要 目的观察氟伐他汀对野百合碱(MCT)所致的肺动脉高压大鼠肺组织5-羟色胺转载体(5-HTT)表达的影响。方法62只大鼠随机分为3组:①M+F组:大鼠首先给予MCT(40 mg/kg)皮下注射和氟伐他汀(1 mg/kg)灌胃,每日各1次,连续2周。第3~6周继续按氟伐他汀初始给药方案灌胃,不再进行MCT皮下注射。②MCT组:实验前2周给予MCT(40 mg/kg)1次/d皮下注射,第3~6周末给予同氟伐他汀等体积的0.9%盐水灌胃 ③Saline组:分别于实验前2周及第3~6周给予等体积的盐水皮下注射和灌胃。分别于不同时间点,对大鼠的血流动力学及相关参数和5-HTT的表达情况进行测定。结果MCT组大鼠于实验第2周末即出现显著的肺动脉高压伴5-HTT蛋白水平异常增高,且在观察期间逐渐增高。M+F组大鼠第6周末出现肺动脉压异常增高,但未伴5-HTT表达增高。结论氟伐他汀能有效抑制5-HTT表达上调,该作用可能与其对大鼠肺动脉高压的抑制作用有关。 Objective To investigate the effect of fluvastatin on serotonin transporter expression in rats with pulmonary arterial hypertension. Methods 62 rats were randomly divided into 3 groups. One group ( M + F, n = 26) received 2-week subcutaneous injection of MCT (40 mg/kg, qd) with a continuous administration of fluvastatin (1 mg/kg) once a day by garage for 6 weeks. Another group (MCT,n =26) received a single subcutaneous injection of MCT (40 mg/kg) in the first 2 weeks,and then were given an equivalent volume of saline garage from 15th day to 42nd day. The third group ( Saline,n = 10) received a 2-week equivalent volume of 0.9% saline injection and a 4-week saline gavage,respectively. Pulmonary arterial pressure (PAP) and serotonin transporter (5-HTT) protein expressions were detected at various time during the 6-week observation. Results Rats in MCT group presented with dramatic PAH together with overexpression of 5-HTT protein at 14th day , which went further in the observation;however,only mild PAIl was observed in M + F group without upregulation of 5-HTT protein at 42nd day. Conclusion Fluvastatin can effectively inhibit overexpression of 5-HTT protein in MCT-induced hypertension, it could possibly correlate with the preventive effect of fluvastatin on rats with pulmonary arterial hypertension.
出处 《实用药物与临床》 CAS 2009年第4期236-237,235,共3页 Practical Pharmacy and Clinical Remedies
关键词 5-羟色胺转载体 氟伐他汀 肺动脉高压 Serotonin transporter Fluvastatin Pulmonary arterial hypertension
  • 相关文献

参考文献7

  • 1Park MH. Advances in diagnosis and treatment in patients with pulmonary arterial hypertension[ J]. Catheterization and Cardio- vascular Interventions,2008,71 (3) :205-213.
  • 2Marcos E, Fadel E, Sanchez O, et al. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hyper- tension[ J]. Cite Res,2004,94(3 ) : 1263-1270.
  • 3Zuckerbraun BS, Chin BY, Wcgiel B, ct al. Carbon monoxide reverses established pulmonary hypertension[ J]. Journal of Experimental Medicine,2006,203 (9) :2109-2119.
  • 4Badesch DB, Abman SH, Simonneau G, et al. Medical therapy for pulmonary medal hypertension:updated ACCP evidencebased clinical practice guidelines [ J ]. Chest, 2007,131 ( 6 ) : 1917-1928.
  • 5Taraseviciene-Stewart L,Scerbavieius R,Choe KH,et al. Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension[ J]. Am J Physiol Lung Cell Mol Physiol,2006,291 ( 6 ) : L668-L676.
  • 6夏秀琼,程德云,苏巧俐,陈小菊,杨莉.斯伐他汀抑制血管紧张素-Ⅱ受体1的表达,预防大鼠低氧性肺动脉高压[J].中国呼吸与危重监护杂志,2007,6(3):213-216. 被引量:8
  • 7邢西迁,甘烨,吴尚洁.他汀类药物治疗肺动脉高压作用机制的研究进展[J].国际呼吸杂志,2007,27(10):794-797. 被引量:4

二级参考文献13

  • 1Morrell NW,Upton PD,Higham MA,et al.Angiotension Ⅱ stimulates proliferation of human pulmonary artery smooth muscle cells via the AT1 receptor.Chest,1998,114:90S-91S.
  • 2Chassagne C,Eddahibi S,Adamy C,et al.Modulation of angiotension Ⅱ receptor expression during development and regression of hypoxic pulmonary hypertension.Am J Respir Cell Mol Biol,2000,22:323-332.
  • 3Rubin LJ.Therapy of pulmonary hypertension:the evolution from vasodilators to antiproliferatiove agents.Am J Respir Crit Care Med,2002,166:1308-1309.
  • 4Girgis RE,Li D,Zhan X,et al.Attenuation of chronic hypoxic pulmonary hypertension by simvastatin.Am J Physiol Heart Circ Physiol,2003,285:H938-H945.
  • 5Glorioso N,Troffa C,Filigheddu F,et al.Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia.Hypertension,1999,34:1281-1286.
  • 6Ichiki T,Takeda K,Tokunou T,et al.Downregulation of angiotension Ⅱ type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells.Arterioscler Thromb Vasc Biol,2001,21:1896-1901.
  • 7Endo A,Kuroda M,Tsujita Y.ML-236A,ML-236B,and ML-236C,new inhibitors of cholesterogenesis produced by Penicillium citrinium.J Antibiot(Tokyo),1976,29:1346-1348.
  • 8Tobert JA.New developments in lipid-lowering therapy:the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation,1987,76:534-538.
  • 9Wassmann S,Laufs U,Baumer AT,et al.HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.Hypertension,2001,37:1450-1457.
  • 10Kandoussi A,Martin F,Hazzan M,et al.HMG-CoA reductase inhibition and PPAR-alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells.Clin Sci(Lond),2002,103:81S-83S.

共引文献10

同被引文献47

  • 1夏秀琼,程德云,苏巧俐,陈小菊,杨莉.辛伐他汀对大鼠低氧性肺动脉高压的作用[J].中华结核和呼吸杂志,2007,30(5):386-388. 被引量:10
  • 2夏秀琼,程德云,苏巧俐,陈小菊,杨莉.斯伐他汀抑制血管紧张素-Ⅱ受体1的表达,预防大鼠低氧性肺动脉高压[J].中国呼吸与危重监护杂志,2007,6(3):213-216. 被引量:8
  • 3McLaughlin W,Archer SL,Badesch DB,et al.ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society,Inc.; and the Pulmonary Hypertension Association.J Am Coll Cardiol,2009,53:1573-1619.
  • 4Eddahibi S,Morrell N,d' Ortho MP,et al.Pathobiology of pulmonary arterial hypertension.Eur Respir J,2002,20:1559 -1572.
  • 5Nishimura T,Vaszar LT,Faul JL,et al Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.Circulation,2003,108:1640-1645.
  • 6Satoh K,Fukumoto Y,Nakano M,et al.Statin ameliorates hypoxia-induced pulmonary hypertension associated with down regulated stromal cell-derived factor-1.Cardiovasc Res,2009,81:226-234.
  • 7Hsu HH,Ko WJ,Hsu JY,et al.Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-1dependent pathway in rats.Respir Res,2009,10:32.
  • 8Nishimura T,Faul JL,Berry GJ,et al.Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.Am J Respir Crit Care Med,2002,166:1403-1408.
  • 9Girgis RE,Mozammel S,Champion HC,et al.Regression of chronic hypoxic pulmonary hypertension by simvastatin.Am J Physiol Lung Cell Mol Physiol,2007,292:L1105-1110.
  • 10Murata T,Kinoshita K,Hori M,et al.Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension.Arterioscler Thromb Vasc Biol,2005,25:2335-2342.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部